<DOC>
	<DOCNO>NCT00370474</DOCNO>
	<brief_summary>Magnetic navigation permit delivery LV lead tip prospectively define location efficiently high proportion patient possible manual navigation .</brief_summary>
	<brief_title>MAGNET CRT Feasibility - Efficiency LV Lead Placement Comparing Conventional v . Magnetic Guidance</brief_title>
	<detailed_description>MAGNET CRT design compare magnetic navigation manual ( i.e. , traditional ) navigation place over-the-wire ( OTW ) leave ventricle ( LV ) lead target site identify investigator . This prospective , randomize , multicenter trial randomization ( 2:1 , magnetic : manual navigation ) occur patient-specific target site identify two hardcopy x-ray image coronary venogram . The target area identify upon review venogram patient ’ coronary venous system take current procedure . Other variable navigate vasculature potential target site ( especially path tortuous ) , achieve good contact myocardium , provide reposition need , counter heart motion , retrograde blood flow , maintain stable delivery system release lead , determinant success LV lead placement . The Magnetic Navigation System ( MNS ) may thus aid coronary venous vasculature navigation guidewires over-the-wire ( OTW ) leave ventricular ( LV ) pace lead placement assist direct tip guidewire , regardless tortuosity give patient ’ anatomy . No investigational product use conduct study . The Niobe® Magnetic Navigation System Stereotaxis guidewires disposable product utilize receive US market clearance , protocol application within specify intend use .</detailed_description>
	<criteria>Inclusion Criteria/ 1 . The patient 18 year age old . 2 . The patient clinically indicate leave ventricular lead placement part pace defibrillator system . 3 . The patient may safely expose magnetic field exist Niobe® MNS laboratory . 4 . The patient participate clinical trial study would conflict guidewire navigation/LV lead implant protocol study . 5 . The patient pregnant , childbearing potential complete pregnancy test result negative . 6 . The patient implant pacemaker defibrillator , unless device explanted otherwise deactivated procedure . 7 . The patient contraindication contrast dye injection . 8 . The patient ’ diastolic blood pressure great 40 mm Hg . 9 . In opinion investigator , patient ’ general health status preclude participation study . 10 . In opinion investigator , patient reasonable candidate participation study . 11 . The patient expect undergo heart transplant next 6 month . 12 . The patient mechanical triscupid heart valve . 13 . The patient myocardial infarction , unstable angina , percutaneous coronary intervention , coronary artery bypass graft precede 30 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Bi-V lead</keyword>
	<keyword>Magnetic Navigation</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
</DOC>